<?xml version="1.0" encoding="UTF-8"?>
<p>There is currently no drug or vaccine to prevent the SARS-CoV-2 infection, but the use of widespread antivirals can be effective against the prophylaxis of this virus (Boopathi et al., 
 <xref rid="CIT0008" ref-type="bibr">2020</xref>; Elmezayen et al., 
 <xref rid="CIT0020" ref-type="bibr">2020</xref>). For example, chloroquine and remdesivir (RDV, GS-5734) are two drugs that in vitro studies have suggested that they can inhibit the viral replication (Wang et al., 
 <xref rid="CIT0069" ref-type="bibr">2020</xref>). Teicoplanin, oritavancin, dalbavancin, and monensin antibiotics also prevent viral replication (Andersen et al., 
 <xref rid="CIT0005" ref-type="bibr">2020</xref>). Currently, the BSAAs are treatment or pyrophylaxis candidates against SARS-CoV-2 (Senanayake, 
 <xref rid="CIT0061" ref-type="bibr">2020</xref>).
</p>
